Journal of Equine Veterinary Science
Volume 27, Issue 3 , Pages 112-117, March 2007

Use of a Mycobacterial Cell Wall Extract (MCWE) in Susceptible Mares to Clear Experimentally Induced Endometritis With Streptococcus zooepidemicus

  • D. Rogan, DVM, MSc, PhD

      Affiliations

    • From Bioniche Animal Health, Ontario, Canada
    • Corresponding Author InformationReprint requests: D. Rogan, Bioniche Animal Health, P.O. Box 1570, Belleville, Ontario, Canada, K8N 5J2.
  • ,
  • E. Fumuso, DVM, PhD

      Affiliations

    • Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina
  • ,
  • E. Rodríguez, DVM, MSc

      Affiliations

    • Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina
  • ,
  • J. Wade, DVM, PhD

      Affiliations

    • Bioniche Animal Health (Europe), Co. Meath, Ireland
  • ,
  • S.F. Sánchez Bruni, DVM, PhD

      Affiliations

    • Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina
    • Consejo Nacional de Investigaciones Científicas y Tecnológicas, Argentina

Abstract 

The ability of an immunomodulator, mycobacterial cell wall extract (MCWE), to clear uterine infection in susceptible mares after an experimental challenge with Streptococcus zooepidemicus was evaluated. Thirty mares susceptible to endometritis, based on the presence of uterine fluid during both diestrus and estrus, were selected from a herd of 896 and inoculated with a live culture of 5 × 106 CFU of S. zooepidemicus on day 1 of estrus. Twenty-four hours later, mares were evaluated by ultrasonography, bacteriology, exfoliative cytology, and uterine biopsy to confirm infection. Forty-eight hours after inoculation, and on confirmation of uterine infection, mares were randomly assigned to one of four unbalanced experimental treatments to receive 1500 μg MCWE IU (n = 10) or IV (n = 10), or placebo IU (n = 5) or IV (n = 5). Mares were examined at ovulation and 7 days post-ovulation for uterine fluid via transrectal ultrasonography and for bacteriology, exfoliative cytology, and uterine biopsy. Efficacy was based on the ability of the mare to clear endometritis as determined by negative bacteriology and reduced numbers of polymorphonuclear cells (PMNs) on uterine biopsy. Because no statistical difference was detected between routes of administration on day 7 post-ovulation, the data sets were combined and re-analyzed to evaluate overall efficacy. Endometritis was observed in all placebo-treated mares 7 days post-ovulation, whereas treatment with MCWE resulted in the elimination of endometritis in 35% of the mares by the time of ovulation, and 70% of the mares by 7 days post-ovulation. Treatment with MCWE, compared with the placebo group, resulted in a significant decrease in the number of mares positive for endometritis at ovulation based on exfoliative cytology and bacteriology (P < .01) and at 7 days post-ovulation based on biopsy, exfoliative cytology, and bacteriology (P < .001). Results indicate that MCWE was an effective treatment for the elimination of endometritis caused by S. zooepidemicus in mares.

Keywords: Mycobacterial cell wall extract (MCWE), Immunomodulation, Innate immunity, Endometritis, Mares

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 15.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Refereed

PII: S0737-0806(07)00049-4

doi:10.1016/j.jevs.2007.01.010

Journal of Equine Veterinary Science
Volume 27, Issue 3 , Pages 112-117, March 2007